Alphatec Holdings (ATEC)
In a report released today, Jason Wittes from Northland Securities maintained a Buy rating on Alphatec Holdings, with a price target of $9.00. The company’s shares closed last Wednesday at $5.87.
Wittes has an average return of 2.9% when recommending Alphatec Holdings.
According to TipRanks.com, Wittes is ranked #800 out of 6895 analysts.
Currently, the analyst consensus on Alphatec Holdings is a Strong Buy with an average price target of $9.00, which is a 56.5% upside from current levels. In a report issued on August 6, Canaccord Genuity also maintained a Buy rating on the stock with a $9.00 price target.
BioMarin Pharmaceutical (BMRN)
Oppenheimer analyst Leland Gershell maintained a Hold rating on BioMarin Pharmaceutical today and set a price target of $88.00. The company’s shares closed last Wednesday at $76.72.
According to TipRanks.com, Gershell is a 5-star analyst with an average return of 15.4% and a 51.3% success rate. Gershell covers the Healthcare sector, focusing on stocks such as Milestone Pharmaceuticals, Corbus Pharmaceuticals, and Miragen Therapeutics.
BioMarin Pharmaceutical has an analyst consensus of Moderate Buy, with a price target consensus of $116.68, a 36.0% upside from current levels. In a report issued on August 5, BMO Capital also maintained a Hold rating on the stock with a $108.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.